Literature DB >> 6291092

Therapeutic alternatives in the treatment of intrahepatic biliary obstruction.

G K McLean, E J Ring, D B Freiman.   

Abstract

Intrahepatic biliary obstruction was treated in 60 patients (49 with cholangiocarcinoma and 11 with sclerosing cholangitis) who were classified according to the upper limit of their obstruction (Group I, proximal common hepatic duct; Group 2, right and left main hepatic ducts; Group 3, intrahepatic bile ducts). Thirty-six patients underwent percutaneous transhepatic biliary drainage, and 14 underwent catheterization through a T-tube track, Five of this latter group had the T-tube placed to establish a route of access for later interventional radiologic manipulations. Since most diseases that produce intrahepatic biliary obstruction are progressive, the use of any single approach is limited. The advantages of a surgically created route of access combined with the flexibility of interventional radiologic techniques help to maximize the therapy and extend the palliation that many of these patients receive.

Entities:  

Mesh:

Year:  1982        PMID: 6291092     DOI: 10.1148/radiology.145.2.6291092

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Primary sclerosing cholangitis in India.

Authors:  S K Acharya; S Vashisht; R K Tandon
Journal:  Gastroenterol Jpn       Date:  1989-02

Review 2.  Radiologic approach to malignant biliary obstruction: review and commentary.

Authors:  E J Ring
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Aug-Sep       Impact factor: 2.740

3.  Percutaneous transhepatic biliary drainage: alternatives in left hepatic duct obstruction.

Authors:  R Uflacker; G S Mourão; R L Piske; S Lima
Journal:  Gastrointest Radiol       Date:  1989

4.  Cholangiocarcinoma. Role of percutaneous transhepatic cholangiography in determination of resectability.

Authors:  R B Lynn; J A Wilson; K J Cho
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.